Hudock Inc’s Ionis Pharmaceuticals IONS Stock Holding History

Hudock Inc’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-300	Closed	-$18K	–	594
2015 Q4	$18K	Hold	300	–	–	0.01%	322
2015 Q3	$12K	Hold	300	–	–	0.01%	380
2015 Q2	$17K	Hold	300	–	–	0.01%	341
2015 Q1	$19K	Hold	300	–	–	0.01%	343
2014 Q4	$19K	Hold	300	–	–	0.01%	327
2014 Q3	$12K	Hold	300	–	–	0.01%	372
2014 Q2	$10K	Hold	300	–	–	0.01%	398
2014 Q1	$13K	Buy	+300	New	+$14.5K	0.01%	350

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Hudock Inc's IONS Position: Q1 2016 in Review

Hudock Inc sold out of Ionis Pharmaceuticals (IONS) in Q1 2016, closing a stake of 300 shares — an estimated $18K sold.

Hudock Inc first reported a position in IONS in Q1 2014 and held it in 8 quarters. The position peaked at $19K in Q1 2015. 314 funds tracked by Wall St. Rank hold IONS as of Q1 2016.

Hudock Inc reported no remaining Ionis Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Hudock Inc sold 300 Ionis Pharmaceuticals shares in Q1 2016, an estimated $18K.
Hudock Inc first reported a position in Ionis Pharmaceuticals in Q1 2014 and held it in 8 quarters.
Hudock Inc's Ionis Pharmaceuticals position peaked at $19K in Q1 2015.
314 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2016.

Based on Hudock Inc's 13F filing for Q1 2016, filed 5 May 2016.